Isracann Bioscience Inc. (ISCNF)

[pual]

The appointment of Mr. Phil Floucault (CEO) seems to have given back life to a company that was in a deep coma. Instead of sitting on his hands waiting for plan ‘A’ to go, he decided to create a complementary plan ‘B’.

‘With the COVID-19 global pandemic (and) the continued governmental delays' our CEO has decided to advance a 'parallel opportunity which can be integrated and leveraged with the Israeli business operation in future’.

‘The Company also signed an agreement with Promethean Marketing to provide digital marketing services’.